Congress Demands Answers on Data Privacy Ahead of 23andMe Sale

Members of Congress are voicing concerns about the data privacy implications surrounding the recent announcement of the sale of 23andMe, a popular genetic testing company.

Lawmakers are demanding answers from 23andMe on how they plan to protect the sensitive genetic information of their customers in the event of a sale.

The sale of 23andMe has raised questions about the potential misuse of genetic data and the need for stronger privacy protections.

Congress is calling for transparency and accountability from 23andMe to ensure that consumer data is not exploited for profit.

Privacy advocates are urging lawmakers to take action to safeguard the genetic information of millions of Americans who have used 23andMe’s services.

Concerns about data privacy have been mounting in recent years as more companies amass vast amounts of personal information from consumers.

The sale of 23andMe has reignited the debate over who owns genetic data and how it should be protected from misuse.

Congress is considering legislative measures to strengthen data privacy laws and hold companies accountable for safeguarding consumer information.

The outcome of the 23andMe sale could have far-reaching implications for the future of data privacy in the United States.

Lawmakers are committed to ensuring that consumers’ privacy rights are protected in the digital age and are prepared to take action to address any breaches of trust.